NEC tumors were associated with a longer time to treat compared to matched cases, and in a subpopulation of IDH wildtype glioblastomas based on histological diagnosis, they had a longer time to initiate treatment and lower survival [21]. The gene discussed is IDH2; the disease is glioblastoma.